Directory

>

Mark Cobbold

avatar

Mark Cobbold

SVP, IO Discovery & Cell Therapy Oncology | AstraZeneca

Boston, Massachusetts, United States

View contact details (it's free)

Mark Cobbold

Summary

Mark Cobbold is a highly accomplished leader in the field of oncology, currently serving as the Senior Vice President of IO Discovery & Cell Therapy Oncology at AstraZeneca. With a robust background in immunology and biotechnology, he has co-founded several innovative companies, including Gritstone Oncology and Revitope, and has held significant academic positions at prestigious institutions like Harvard University. His expertise spans a wide range of topics, including cancer immunotherapy and drug discovery, making him a sought-after figure in the life sciences sector. Mark's career reflects a commitment to advancing cancer research through both academic and entrepreneurial endeavors. His work not only focuses on developing breakthrough therapies but also on mentoring the next generation of scientists. He is recognized for his contributions to the field and is passionate about translating research into impactful clinical solutions.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Startup Experience

Corporate Experience

Consulting Experience

Non-Profit Experience

Mark Cobbold

Work Experience

company logo

SVP, IO Discovery & Cell Therapy Oncology at

AstraZeneca

March 2024 - Present

company logo

Scientific Co-Founder at

GigaMune

January 2019 - Present

company logo

Scientific co-founder at

Gritstone bio

October 2015 - Present

company logo

Scientific Founder at

Revitope

November 2014 - Present

company logo

VP Oncology Early Discovery at

AstraZeneca

September 2019 - March 2024

company logo

Associate Member at

The Broad Institute Inc

September 2015 - September 2019

company logo

Associate Professor of Medicine at

Harvard University

June 2015 - September 2019

company logo

Associate Professor at

Massachusetts General Hospital

June 2015 - September 2019

💼

Scientific Co-Founder at

SERASCIENCE LIMITED

May 2011 - June 2015

💼

Scientific Co-Founder at

PhosImmune Inc.

September 2012 - June 2015

company logo

Reader in Translational Immunology at

University of Birmingham Accommodation Services

March 2014 - May 2015

company logo

Senior Clinical Research Fellow (Tumour Immunology) at

University of Birmingham Accommodation Services

September 2009 - March 2014

company logo

MRC Clinician Scientist at

University of Birmingham Accommodation Services

January 2003 - January 2009

company logo

Visiting Clinical Research Fellow at

Rector & Visitors of The University of Virginia

January 2006 - December 2007

Logos provided by Logo.dev

Mark Cobbold

Education

University of Birmingham, Phd

January 2000 - January 2003

Frequently Asked Questions about Mark Cobbold

What is Mark Cobbold email address?

Mark Cobbold's primary email address is ************@astrazeneca.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Mark Cobbold work for?

Mark Cobbold is a SVP, IO Discovery & Cell Therapy Oncology at AstraZeneca, a company specializing in Pharmaceutical & Medicine Manufacturing.

Where Mark Cobbold graduated from?

Mark Cobbold holds a degree in Immunology / Immunotherapy from University of Birmingham.

How can I directly contact Mark Cobbold?

To contact Mark Cobbold directly, you can use the email address ************@astrazeneca.com. Complete contact information is available upon registration with Muraena.

Who is Mark Cobbold?

Mark Cobbold is a highly accomplished leader in the field of oncology, currently serving as the Senior Vice President of IO Discovery & Cell Therapy Oncology at AstraZeneca. With a robust background in immunology and biotechnology, he has co-founded several innovative companies, including Gritstone Oncology and Revitope, and has held significant academic positions at prestigious institutions like Harvard University. His expertise spans a wide range of topics, including cancer immunotherapy and drug discovery, making him a sought-after figure in the life sciences sector. Mark's career reflects a commitment to advancing cancer research through both academic and entrepreneurial endeavors. His work not only focuses on developing breakthrough therapies but also on mentoring the next generation of scientists. He is recognized for his contributions to the field and is passionate about translating research into impactful clinical solutions.

Mark`s contact details

mail

************@astrazeneca.com

*********@bham.ac.uk

Colleagues

avatar
Therese Meaney

Vice President, Insights & Analytics

avatar
Lara Martinez Gonzalez

Advisory Board Member

avatar
Serenia Moore

Executive Board Member

avatar
Fernanda Arnaldez

Executive Medical Director / Global Product Leader - Early Development, Oncology R&D

avatar
Deborah Di Sanzo

President, Best Buy Health

avatar
Diana Layfield

GM Search International and Growth

avatar
Donna French

Member Board Of Trustees

avatar
Renee Iacona

Chief Operating Officer - Oncology R&D

avatar
Iain Chessell

VP & Head, Neuroscience, BioPharma R&D, AstraZeneca

View Contact details (it's free)
Request Profile Removal